Filing Details

Accession Number:
0001062993-22-013050
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-19 18:16:46
Reporting Period:
2022-05-17
Accepted Time:
2022-05-19 18:16:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1828522 Effector Therapeutics Inc. EFTR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1225480 D Jonathan Root 1460 El Camino Real
Suite 100
Menlo Park CA 94025
No No Yes No
1440514 Us Venture Partners X Lp 1460 El Camino Real, Ste 100
Menlo Park CA 94025
No No Yes No
1453359 Usvp X Affiliates Lp 1460 El Camino Real, Ste 100
Menlo Park CA 94025
No No Yes No
1474322 M Casey Tansey 1460 El Camino Real
Suite 100
Menlo Park CA 94025
No No Yes No
1602744 Presidio Management Group X Llc 1460 El Camino Real, Ste 100
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-05-17 11,402 $1.75 4,280,691 No 4 S Indirect Directly owned by USVP X
Common Stock Disposition 2022-05-17 365 $1.75 136,944 No 4 S Indirect Directly owned by AFF X
Common Stock Disposition 2022-05-18 13,649 $1.73 4,267,042 No 4 S Indirect Directly owned by USVP X
Common Stock Disposition 2022-05-18 437 $1.73 136,507 No 4 S Indirect Directly owned by AFF X
Common Stock Disposition 2022-05-19 8,308 $1.69 4,258,734 No 4 S Indirect Directly owned by USVP X
Common Stock Disposition 2022-05-19 266 $1.69 136,241 No 4 S Indirect Directly owned by AFF X
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Directly owned by USVP X
No 4 S Indirect Directly owned by AFF X
No 4 S Indirect Directly owned by USVP X
No 4 S Indirect Directly owned by AFF X
No 4 S Indirect Directly owned by USVP X
No 4 S Indirect Directly owned by AFF X
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.82, inclusive for sales on 5/17/22; prices ranging from $1.70 to $1.93, inclusive for sales on 5/18/22; and prices ranging from $1.63 to $1.78, inclusive for sales on 5/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  2. Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.